U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8BrF17
Molecular Weight 498.962
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PERFLUBRON

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br

InChI

InChIKey=WTWWXOGTJWMJHI-UHFFFAOYSA-N
InChI=1S/C8BrF17/c9-7(22,23)5(18,19)3(14,15)1(10,11)2(12,13)4(16,17)6(20,21)8(24,25)26

HIDE SMILES / InChI

Molecular Formula C8BrF17
Molecular Weight 498.962
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191624/

Perflubron is a contrast agent used for signal enhancement during the indicated ultrasound imaging procedures. Perflubron is a constituent of blood substitute, indicated for liquid breathing.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
IMAGENT

Approved Use

To use in subjects with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.

Launch Date

1994
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
0.16 mg/dL
14 mL/kg single, respiratory
dose: 14 mL/kg
route of administration: Respiratory
experiment type: SINGLE
co-administered:
PERFLUBRON serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
High-frequency oscillatory ventilation of the perfluorocarbon-filled lung: dose-response relationships in an animal model of acute lung injury.
2001 Apr
Intratracheal administration of perfluorochemical-gentamicin suspension: a comparison to intravenous administration in normal and injured lungs.
2001 Aug
Selective tracheal gas insufflation during partial liquid ventilation improves lung function in an animal model of unilateral acute lung injury.
2001 Dec
Pulmonary arterial morphometry from microfocal X-ray computed tomography.
2001 Dec
Perflubron emulsion reduces inflammation during extracorporeal circulation.
2001 Jul
Optimizing intrapulmonary perfluorocarbon distribution: fluoroscopic comparison of mode of ventilation and body position.
2001 Mar
Seventy-two hours hypothermic intestinal preservation study using a new perfluorocarbon emulsion.
2001 May
Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils.
2001 Nov
Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature.
2001 Nov 15
Using liquid ventilation to treat patients with acute respiratory distress syndrome: a guide to a breath of fresh liquid.
2001 Oct
Partial liquid ventilation with low dose of perflubron and a low stretch ventilation strategy improves oxygenation in a rabbit model of surfactant depletion.
2002
Comparison of effects of perflubron and surfactant lung lavage on pulmonary gas exchange in a piglet model of meconium aspiration.
2002
Oxygen carriers.
2002 Aug
A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
2002 Aug
Combined bactericidal activity of perfluorooctyl bromide and aminoglycosides against Pseudomonas aeruginosa.
2002 Dec
Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study.
2002 Dec
Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation.
2002 Dec 5
Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia.
2002 Feb
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.
2002 Jan
Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates.
2002 Jan
Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome.
2002 Mar 15
Effect of perfluorocarbon (perfluorooctyl bromide) vapor on tidal volume measurement during partial liquid ventilation.
2002 May
New strategies in nonoperative management of meconium ileus.
2002 May
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
2002 May 15
Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery.
2002 Oct
Positive end-expiratory pressure modulates perfluorochemical evaporation from the lungs.
2003
Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems.
2003 Apr
End-expiratory lung volumes and density distribution patterns during partial liquid ventilation in healthy and oleic acid-injured sheep: a computed tomography study.
2003 Aug
Mechanism of perfluoroalkyl halide toxicity: catalysis of perfluoroalkylation by reduced forms of cobalamin (vitamin B12).
2003 Dec
Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids.
2003 Dec
Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization.
2003 Jan
Effect of partial liquid ventilation on bacterial clearance during Pseudomonas aeruginosa-induced lung injury in rats.
2003 Jul
Partial liquid ventilation does not affect BALF TNF-, MIP-2, CINC-1 concentrations, or CD11b cell surface expression, but does increase macrophage proportion among BALF cells in the acute phase of rat LPS-induced lung injury.
2003 Jun
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.
2003 Jun 16
Effect of perfluorooctyl bromide on bacterial growth.
2003 May
Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock.
2003 Nov
Extended high-frequency partial liquid ventilation in lung injury: gas exchange, injury quantification, and vapor loss.
2003 Sep
Alternatives to blood in the 21st century.
2004
Blood management in intensive care medicine: CRIT and ABC--what can we learn?
2004 Apr
[Effects of perfluorochemicals on severe hemo-diluted cardiopulmonary bypass in dogs].
2004 Jan
Assessment of the development of choked flow during total liquid ventilation.
2004 Jan
Effects of partial liquid ventilation on lipopolysaccharide-induced inflammatory responses in rats.
2004 Jul
Surface properties and the meconium aspiration syndrome.
2004 Mar
Effect of meconium on the surface properties of perflubron.
2004 Mar
Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia.
2004 May
Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals.
2004 May
[The impact of mechanical ventilation strategies that minimize atelectrauma in an experimental model of acute lung injury].
2004 May-Jun
Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
2004 Sep
Hyperoxia-induced changes in human airway epithelial cells: the protective effect of perflubron.
2005 Mar
Brain pharmacokinetics of lignocaine before and following intravenous perfluorocarbon emulsion infusion in sheep.
2005 May-Jun
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Can be used as oral liquid.
The recommended dose is 0.00625 mL/kg (0.125 mg/kg) administered as a single intravenous bolus over a period of not less than 10 seconds and immediately followed by a saline flush.
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 18:04:29 GMT 2023
Edited
by admin
on Sat Dec 16 18:04:29 GMT 2023
Record UNII
Q1D0Q7R4D9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PERFLUBRON
INN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN  
Official Name English
N-PERFLUOROOCTYL BROMIDE
Common Name English
PERFLUBRON [USP-RS]
Common Name English
OCTANE, 1-BROMO-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-HEPTADECAFLUORO-
Systematic Name English
PERFLUOROCTYL BROMIDE
Common Name English
IMAGENT
Brand Name English
PERFLUBRON [USP MONOGRAPH]
Common Name English
PERFLUBRON [USAN]
Common Name English
LIQUIVENT
Brand Name English
PERFLUBRON [MI]
Common Name English
1-Bromoheptadecafluorooctane
Systematic Name English
OCTANE, 1-BROMOHEPTADECAFLUORO-
Systematic Name English
PERFLUOROCAPRYLYL BROMIDE
INCI  
INCI  
Official Name English
PERFLUBRON [ORANGE BOOK]
Common Name English
PERFLUBRON [VANDF]
Common Name English
PERFLUBRON [MART.]
Common Name English
PERFLUOROOCTYL BROMIDE
Systematic Name English
PERFLUOROCAPRYLYL BROMIDE [INCI]
Common Name English
perflubron [INN]
Common Name English
Perflubron [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-VATC QV08CX01
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
FDA ORPHAN DRUG 630718
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
FDA ORPHAN DRUG 631018
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
NCI_THESAURUS C390
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
WHO-ATC V08CX01
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
NCI_THESAURUS C798
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
FDA ORPHAN DRUG 141100
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
Code System Code Type Description
DRUG BANK
DB05791
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
EVMPD
SUB09721MIG
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
USAN
DD-10
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
ChEMBL
CHEMBL1200866
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
DRUG CENTRAL
2102
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
FDA UNII
Q1D0Q7R4D9
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
EPA CompTox
DTXSID5046560
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
RS_ITEM_NUM
1510801
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
NCI_THESAURUS
C1422
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-028-4
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
WIKIPEDIA
PERFLUBRON
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
PUBCHEM
9873
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
SMS_ID
100000082730
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
MESH
C003072
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
MERCK INDEX
m8540
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY Merck Index
INN
6903
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
CHEBI
38803
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
CAS
423-55-2
Created by admin on Sat Dec 16 18:04:29 GMT 2023 , Edited by admin on Sat Dec 16 18:04:29 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY